Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 5323-5328, October 1, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujita, M.
Right arrow Articles by Enomoto, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujita, M.
Right arrow Articles by Enomoto, T.

Alteration of the p53 Gene in Human Primary Cervical Carcinoma with and without Human Papillomavirus Infection

Masami Fujita, Masaki Inoue, Osamu Tanizawa, Seiichi Iwamoto and Takayuki Enomoto1

Departments of Obstetrics and Gynecology [M. F., M. I., O. T.] and Radiation Biology [T. E.], Osaka University Medical School, 2-2, Yamadaoka, Suita, Osaka 565, and Kanebo Institute for Cancer Research, 9-1, Misakicho-1-chome, Hyogo-ku, Kobe 652, Japan [S. I.]

A previous report using cervical carcinoma cell lines suggests that the inactivation of two tumor suppressor gene products, p53 and pRB, either by complex formation with the E6 and E7 proteins of oncogenic human papillomaviruses (HPVs) or by mutation, may be an important step in cervical carcinogenesis (M. Scheffner et al., Proc. Natl. Acad. Sci. USA, 88: 5523–5527, 1991). The present study was designed to clarify the association between p53 inactivation and infection with oncogenic HPVs in primary carcinomas of human uterine cervix. We examined 36 primary cervical carcinomas for the presence of HPV DNAs by Southern blot analysis with probes specific for HPV-16, -18, -31, -33, -52, -56, and -58. HPV DNA sequences were detected in 19 of 36 tumors: 10 cases with HPV-16; 3 cases with -18; 3 cases with -58; 2 cases with -56; and one case with -52. The presence of HPV-16 and -18 in cervical carcinomas was further reexamined using polymerase chain reaction. HPV DNA sequences were detected in an additional 10 cases: 9 cases with -16 and one case with -18. The inactivation of the p53 gene by allelic loss or by point mutation was also examined. No allelic loss at the polymorphic site in codon 72 of the p53 gene was detected in any of 10 informative cases. Missense point mutations in the highly conserved regions of the p53 gene were demonstrable as single-stranded conformational polymorphisms of polymerase chain reaction-amplified DNA fragments and subsequently identified by direct DNA sequencing. Point mutations were detected in only two cases: one with an ATG->CTG transversion in codon 133 of exon 5, resulting in a Met->Leu substitution, and another with a CGG->TGG transition in codon 248 of exon 7, resulting in an Arg->Trp substitution. Both tumors with point mutations in p53 genes were among 10 tumors which contained a small copy number of HPV-16 DNA sequences (1 copy of HPV/101 to 105 cells) detectable by polymerase chain reaction amplification but not by Southern blot analysis of genomic DNAs derived from the tumors. None of 19 tumors with a large copy number of HPV DNA sequences detectable by Southern blot analysis (more than 1 copy of HPV/2 to 10 cells) nor any of 7 tumors with undetectable HPV DNA sequences contained p53 gene mutations in the regions examined. These observations suggest that, in contrast to data derived from cultured cervical carcinoma cell lines, inactivation of the p53 gene by allelic loss or by point mutation is infrequent in clinical samples of cervical carcinomas of the human uterus, irrespective of the presence or absence of HPV infection.

1 To whom requests for reprints should be addressed.

Received 4/27/92. Accepted 7/20/92.




This article has been cited by other articles:


Home page
J. Virol.Home page
D. Das, K. Wojno, and M. J. Imperiale
BK Virus as a Cofactor in the Etiology of Prostate Cancer in Its Early Stages
J. Virol., March 15, 2008; 82(6): 2705 - 2714.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S Mitra, S Banerjee, C Misra, R K Singh, A Roy, A Sengupta, C K Panda, and S Roychoudhury
Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population
J. Clin. Pathol., September 1, 2007; 60(9): 1040 - 1047.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. S. Liu, K. Y.-K. Chan, R. C.-Y. Leung, H. K.-W. Law, T.-W. Leung, and H. Y.-S. Ngan
Enhancement of the radiosensitivity of cervical cancer cells by overexpressing p73{alpha}
Mol. Cancer Ther., May 1, 2006; 5(5): 1209 - 1215.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y.-W. Cheng, H.-L. Chiou, G.-T. Sheu, L.-L. Hsieh, J.-T. Chen, C.-Y. Chen, J.-M. Su, and H. Lee
The Association of Human Papillomavirus 16/18 Infection with Lung Cancer among Nonsmoking Taiwanese Women
Cancer Res., April 1, 2001; 61(7): 2799 - 2803.
[Abstract] [Full Text]


Home page
PediatricsHome page
S. L. Mount and J. L. Papillo
A Study of 10 296 Pediatric and Adolescent Papanicolaou Smear Diagnoses in Northern New England
Pediatrics, March 1, 1999; 103(3): 539 - 545.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.